Complete regression of mouse mammary carcinoma with a size greater than 15 mm by frequent repeated hyperthermia using magnetite nanoparticles

被引:32
作者
Ito, A
Tanaka, K
Honda, H
Abe, S
Yamaguchi, H
Kobayashi, T [1 ]
机构
[1] Nagoya Univ, Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan
[2] Teikyo Univ, Inst Med Mycol, Hachioji, Tokyo 1920395, Japan
关键词
hyperthermia; magnetite; mammary carcinoma; liposome; tumor size;
D O I
10.1016/S1389-1723(03)90138-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Magnetite cationic liposomes (MCLs) have a positive surface charge and are used as a heating mediator for hyperthermia, because they generate heat in an alternating magnetic field (AMF) due to hysteresis loss. In our previous paper, hyperthermia using MCLs was applied to animals having several types of tumors in mice, rats, hamsters, and rabbits, and a strong anticancer effect was observed. For mice, complete tumor regression was observed when the tumor size was smaller than 5 mm. However, a protocol for large tumors is necessary for the clinical application. In the present paper, a protocol for tumors with a size greater than 15 mm in mice was investigated. MCLs were injected into an MM46 tumor (size, 15 mm) in C3H/HeN mice, which were subjected to AMF for 30 min. The temperature at the surface of the tumor reached 45degreesC and was maintained by controlling the magnetic field intensity. Hyperthermia treatment was repeated twice with 24-h intervals (repeated hyperthermia; RH), and RH was carried out until complete tumor regression was observed. Complete tumor regression was achieved in all mice treated once, twice or six times with RH, and mice acquired antitumor immunity. This protocol, which is termed frequent RH, is a potent approach for cancer therapy.
引用
收藏
页码:364 / 369
页数:6
相关论文
共 26 条
[1]  
ABE M, 1986, CANCER, V58, P1589, DOI 10.1002/1097-0142(19861015)58:8<1589::AID-CNCR2820580802>3.0.CO
[2]  
2-B
[3]  
[Anonymous], 1994, JPN J HYPERTHERMIC O
[4]   HYPERTHERMIA AND THE HEAT-SHOCK PROTEINS OF HELA-CELLS [J].
BURDON, RH ;
SLATER, A ;
MCMAHON, M ;
CATO, ACB .
BRITISH JOURNAL OF CANCER, 1982, 45 (06) :953-963
[5]  
Castelli C, 2001, CANCER RES, V61, P222
[6]   CELLULAR RESPONSES TO COMBINATIONS OF HYPERTHERMIA AND RADIATION [J].
DEWEY, WC ;
HOPWOOD, LE ;
SAPARETO, SA ;
GERWECK, LE .
RADIOLOGY, 1977, 123 (02) :463-474
[7]   MODIFICATION OF CELL LETHALITY AT ELEVATED-TEMPERATURES - PH EFFECT [J].
GERWECK, LE .
RADIATION RESEARCH, 1977, 70 (01) :224-235
[8]   Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma [J].
Ito, A ;
Tanaka, K ;
Kondo, K ;
Shinkai, M ;
Honda, H ;
Matsumoto, K ;
Saida, T ;
Kobayashi, T .
CANCER SCIENCE, 2003, 94 (03) :308-313
[9]   Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles [J].
Ito, A ;
Shinkai, M ;
Honda, H ;
Yoshikawa, K ;
Saga, S ;
Wakabayashi, T ;
Yoshida, J ;
Kobayashi, T .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (02) :80-88
[10]   Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia [J].
Ito, A ;
Shinkai, M ;
Honda, H ;
Wakabayashi, T ;
Yoshida, J ;
Kobayashi, T .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001, 50 (10) :515-522